Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2002
09/26/2002US20020137059 Microdevice containing photorecognizable coding patterns and methods of using and producing the same thereof
09/26/2002US20020137058 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/26/2002US20020137056 Calibration of signals
09/26/2002US20020137053 Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
09/26/2002US20020137052 System and apparatus for sequential processing of analytes
09/26/2002US20020137049 Pablo, a polypeptide that interacts with Bcl-xL, and uses related thereto
09/26/2002US20020137046 Detection uisng mass spectrometry
09/26/2002US20020137040 Polymorphism in p21 waf1/cip1 gene, association with human cancer and uses related thereto
09/26/2002US20020137038 Intestinal proteins
09/26/2002US20020137036 Polymerase chain reaction
09/26/2002US20020137033 Veterinary medicine; analyzing animal Dna
09/26/2002US20020137032 Test device, measurement means, computers
09/26/2002US20020137028 Use of neuronal apoptosis inhibitor protein (naip)
09/26/2002US20020137027 Using optical indicator
09/26/2002US20020137026 Detection and characterization of microorganisms
09/26/2002US20020137025 Sampling body fluid; analyzing using code for detection of sample
09/26/2002US20020137023 Methods and compositions for targeting compounds to muscle
09/26/2002US20020137018 Screening for antitumor agents
09/26/2002US20020136978 Transfer of arrayed chemical compositions
09/26/2002US20020136821 Microarray fabricating device
09/26/2002US20020136754 Recombinant bacterial phytases and uses thereof
09/26/2002US20020136739 Subunit respiratory syncytial virus preparation
09/26/2002US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family
09/26/2002US20020136719 For biomedical applications, including biological delivery to humans and animals
09/26/2002US20020136718 Using antibody which catalyzes hydrolysis of beta-amyloid at a predetermined amide linkage
09/26/2002US20020136717 Process for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1 binding domain or a protein having an EVH1 binding domain, and a process for detecting said interaction
09/26/2002US20020136692 Contrast enhancement agent for magnetic resonance imaging
09/26/2002US20020136689 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds
09/26/2002US20020136436 Devices and methods for reading and interpreting guaiac-based occult blood tests
09/26/2002US20020135771 System and method of reducing particulate interference in fluid analyte detection
09/26/2002US20020135632 Process for producing probe carrier and apparatus thereof
09/26/2002US20020135377 Sensor and sensor system for liquid conductivity, temperature and depth
09/26/2002US20020135365 Method for high resolution magnetic resonance analysis using magic angle technique
09/26/2002US20020135358 Method and apparatus for detection and measurement of accumulations of magnetic particles
09/26/2002US20020134722 Ultrapure water producing apparatus
09/26/2002US20020134718 Apparatus for screening compound libraries
09/26/2002US20020134678 One-piece harness and upper shield design and the method of making the same
09/26/2002US20020134677 Intrinsic shorting link for gas sensors
09/26/2002US20020134523 Arrangement for paper machine, and blow box
09/26/2002US20020134148 Method of wear testing a tire
09/26/2002DE10113876A1 Quantitative diagnosis of genetically related hypertension, by correlating blood pressure with overexpression or modification of human sgk family proteins
09/26/2002DE10113646A1 Remote use fluid testing device has sensors linked to palm computer via modular interface and power supply
09/26/2002DE10113042A1 Identifying compounds that modify interaction of gp120 and co-receptors, useful potentially for treating human immune deficiency virus infection, also new peptides
09/26/2002DE10112298A1 Measurement chamber attachment for a chemical or bio sensor, for repeated use, is a shaped body with an inner recess for a capillary action, to give a flow of a buffer/sample/flushing medium which is reproducible and reversible
09/26/2002DE10110960A1 Testing living tissue, to identify illness caused by mutated prions e.g. BSE, comprises recovery of plasminogen from blood sample and binding to amino acid for evaluation by laser fluorescence
09/26/2002DE10110838A1 Diagnosis of allergies, pseudo-allergies and intolerances, comprises measuring the increased concentrations of pentane and isoprene in the exhaled air after the administration of a trigger substance
09/26/2002DE10109019A1 System to determine composition of biological structure, in foodstuff industry, uses picture where digital image signals are evaluated by color tints to identify component parts of structure
09/26/2002DE10108680A1 Test strips for the assay of biological materials, for clinical diagnosis etc. carry affinity molecules and can take or support a flow to give time-related reactions
09/26/2002CA2852293A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom
09/26/2002CA2771039A1 Device and method for the photodynamic diagnosis of tumor tissue
09/26/2002CA2768116A1 Neurofibrillary labels
09/26/2002CA2458141A1 Device and method for automatically producing a thermal recoil response in nematodes
09/26/2002CA2442345A1 A microfluidic system (ms)
09/26/2002CA2442342A1 A microfluidic system (edi)
09/26/2002CA2441673A1 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor
09/26/2002CA2441510A1 Muteins of hypoxia inducible factor alpha and methods of use thereof
09/26/2002CA2441339A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
09/26/2002CA2441291A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
09/26/2002CA2441279A1 Fluorescent polymer superquenching-based bioassays
09/26/2002CA2441254A1 Examination device and method for examination of chemical and/or biological samples
09/26/2002CA2441206A1 Characterization of reaction variables
09/26/2002CA2441170A1 Method and kit for following neurodegenerative diseases
09/26/2002CA2441163A1 Analysing device for analysing chemical and/or biological samples
09/26/2002CA2441155A1 Methods of treating respiratory conditions
09/26/2002CA2441104A1 Method of detecting amyloid-containing lesions by autofluorescence
09/26/2002CA2441086A1 Identification of gene expression alterations underlying the aging process in mammals
09/26/2002CA2441042A1 Monoclonal antibody therapy for pancreas cancer
09/26/2002CA2440960A1 An early pre-symptomatic prion diagnostic blood test for encephalopathies
09/26/2002CA2440819A1 Method for generating a hierarchical topological tree of 2d or 3d-structural formulas of chemical compounds for property optimisation of chemical compounds
09/26/2002CA2440793A1 Predicting metabolic stability of drug molecules
09/26/2002CA2440749A1 Isolation and purification procedure of vasopeptidase peptide inhibitors
09/26/2002CA2440623A1 Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related diseasestates
09/26/2002CA2440584A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
09/26/2002CA2440272A1 Nucleic acid-associated proteins
09/26/2002CA2440028A1 Rearranged squamous cell carcinoma antigen genes ii
09/26/2002CA2439627A1 Structural units that define fluidic functions
09/26/2002CA2439532A1 Methods and reagents for regulating apoptosis
09/26/2002CA2438483A1 Histidine phosphatase interacting protein with 240kd
09/26/2002CA2438315A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom
09/26/2002CA2437753A1 Multiplex protein interaction determinations using glutathione-gst binding
09/26/2002CA2435664A1 Ncc2705-the genome of a bifidobacterium
09/25/2002EP1244047A2 Method for providing clinical diagnostic services
09/25/2002EP1243928A1 Means of stabilizing compositions and reagents
09/25/2002EP1243927A1 Short turnaround time insulin assay
09/25/2002EP1243926A2 Diffusion-controlling sensor layer
09/25/2002EP1243925A2 Biochemical examination method
09/25/2002EP1243924A1 Reagents and solid phase components in specific binding assays free of advanced glycosylation endproducts
09/25/2002EP1243923A1 METHOD OF SCREENING REMEDY FOR CANCER WITH THE USE OF INTERACTION DOMAINS OF p53 AND MORTALIN
09/25/2002EP1243921A2 A method for self-cleaning of a photo-ionization detector for volatile gases
09/25/2002EP1243914A2 Method of evaluating degree of hair damage
09/25/2002EP1243913A2 Method for the analysis of the metal chelates of amino acids
09/25/2002EP1243911A1 Device for tissue preparation
09/25/2002EP1243910A1 Device for tissue preparation and holder for processing receptacle for tissue preparation
09/25/2002EP1243907A2 Method and apparatus for sample analysis
09/25/2002EP1243658A1 Method of measuring deacetylase activity and method of screening inhibitor or promoter of these enzymes
09/25/2002EP1243655A1 Modified HPV E6 and E7 genes and proteins useful for vaccination
09/25/2002EP1243646A2 Transgenic Drosophila with human APC gene for pharmacological screenings
09/25/2002EP1243644A1 Method for investigating the conditions in a container
09/25/2002EP1243610A1 Nano-scaled dendrimer-based colorimetric biosensors
09/25/2002EP1243597A2 Receptors for human interleukin-12